Literature DB >> 33991013

Elevated fibroblast growth factor-inducible 14 expression transforms proneural-like gliomas into more aggressive and lethal brain cancer.

Nina P Connolly1,2, Rebeca Galisteo3,4, Su Xu5,6, Eli E Bar1,2,7, Sen Peng8, Nhan L Tran9, Heather M Ames2,7, Anthony J Kim1,2, Graeme F Woodworth1,2, Jeffrey A Winkles1,2,3,4.   

Abstract

High-grade gliomas (HGGs) are aggressive, treatment-resistant, and often fatal human brain cancers. The TNF-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) signaling axis is involved in tissue repair after injury and constitutive signaling has been implicated in the pathogenesis of numerous solid cancers. The Fn14 gene is expressed at low levels in the normal, uninjured brain but is highly expressed in primary isocitrate dehydrogenase wild-type and recurrent HGGs. Fn14 signaling is implicated in numerous aspects of glioma biology including brain invasion and chemotherapy resistance, but whether Fn14 overexpression can directly promote tumor malignancy has not been reported. Here, we used the replication-competent avian sarcoma-leukosis virus/tumor virus A system to examine the impact of Fn14 expression on glioma development and pathobiology. We found that the sole addition of Fn14 to an established oncogenic cocktail previously shown to generate proneural-like gliomas led to the development of highly invasive and lethal brain cancer with striking biological features including extensive pseudopalisading necrosis, constitutive canonical and noncanonical NF-κB pathway signaling, and high plasminogen activator inhibitor-1 (PAI-1) expression. Analyses of HGG patient datasets revealed that high human PAI-1 gene (SERPINE1) expression correlates with shorter patient survival, and that the SERPINE1 and Fn14 (TNFRSF12A) genes are frequently co-expressed in bulk tumor tissues, in tumor subregions, and in malignant cells residing in the tumor microenvironment. These findings provide new insights into the potential importance of Fn14 in human HGG pathobiology and designate both the NF-κB signaling node and PAI-1 as potential targets for therapeutic intervention. MAIN POINTS: This work demonstrates that elevated levels of the TWEAK receptor Fn14 in tumor-initiating, neural progenitor cells leads to the transformation of proneural-like gliomas into more aggressive and lethal tumors that exhibit constitutive NF-κB pathway activation and plasminogen activator inhibitor-1 overexpression.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  Fn14; NF-κB; PAI-1; RCAS/tv-a model; glioblastoma; high-grade glioma

Mesh:

Substances:

Year:  2021        PMID: 33991013      PMCID: PMC8596752          DOI: 10.1002/glia.24018

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  65 in total

Review 1.  TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses.

Authors:  Linda C Burkly; Jennifer S Michaelson; Timothy S Zheng
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

2.  Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.

Authors:  Tetsumei Urano; Yuko Suzuki; Takayuki Iwaki; Hideto Sano; Naoki Honkura; Francis J Castellino
Journal:  Curr Drug Targets       Date:  2019       Impact factor: 3.465

Review 3.  Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis.

Authors:  Yihai Cao
Journal:  Trends Mol Med       Date:  2013-06-15       Impact factor: 11.951

Review 4.  "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid Sequencing.

Authors:  Adham M Khalafallah; Sakibul Huq; Adrian E Jimenez; Riccardo Serra; Chetan Bettegowda; Debraj Mukherjee
Journal:  Neurosurgery       Date:  2021-02-16       Impact factor: 4.654

5.  A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment.

Authors:  Zuzana Saidak; Simon Soudet; Marine Lottin; Valéry Salle; Marie-Antoinette Sevestre; Florian Clatot; Antoine Galmiche
Journal:  Cancer Immunol Immunother       Date:  2020-10-15       Impact factor: 6.968

6.  Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.

Authors:  Evan M Cherry; Dong W Lee; Ji-Ung Jung; Raquel Sitcheran
Journal:  Mol Cancer       Date:  2015-01-27       Impact factor: 27.401

7.  Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian glioma.

Authors:  Nina P Connolly; Amol C Shetty; Jesse A Stokum; Ina Hoeschele; Marni B Siegel; C Ryan Miller; Anthony J Kim; Cheng-Ying Ho; Eduardo Davila; J Marc Simard; Scott E Devine; John H Rossmeisl; Eric C Holland; Jeffrey A Winkles; Graeme F Woodworth
Journal:  Sci Rep       Date:  2018-01-19       Impact factor: 4.379

8.  Identification of SERPINE1 as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling.

Authors:  Fidan Seker; Ahmet Cingoz; İlknur Sur-Erdem; Nazli Erguder; Alp Erkent; Fırat Uyulur; Myvizhi Esai Selvan; Zeynep Hülya Gümüş; Mehmet Gönen; Halil Bayraktar; Hiroaki Wakimoto; Tugba Bagci-Onder
Journal:  Cancers (Basel)       Date:  2019-10-25       Impact factor: 6.639

9.  The TWEAK Receptor Fn14 Is an Src-Inducible Protein and a Positive Regulator of Src-Driven Cell Invasion.

Authors:  Emily Cheng; Timothy G Whitsett; Nhan L Tran; Jeffrey A Winkles
Journal:  Mol Cancer Res       Date:  2014-11-12       Impact factor: 5.852

10.  Chromosomal instability drives metastasis through a cytosolic DNA response.

Authors:  Samuel F Bakhoum; Bryan Ngo; Ashley M Laughney; Julie-Ann Cavallo; Charles J Murphy; Peter Ly; Pragya Shah; Roshan K Sriram; Thomas B K Watkins; Neil K Taunk; Mercedes Duran; Chantal Pauli; Christine Shaw; Kalyani Chadalavada; Vinagolu K Rajasekhar; Giulio Genovese; Subramanian Venkatesan; Nicolai J Birkbak; Nicholas McGranahan; Mark Lundquist; Quincey LaPlant; John H Healey; Olivier Elemento; Christine H Chung; Nancy Y Lee; Marcin Imielenski; Gouri Nanjangud; Dana Pe'er; Don W Cleveland; Simon N Powell; Jan Lammerding; Charles Swanton; Lewis C Cantley
Journal:  Nature       Date:  2018-01-17       Impact factor: 49.962

View more
  1 in total

1.  Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity.

Authors:  Gökhan Güner; Marlene Aßfalg; Kai Zhao; Tobias Dreyer; Shibojyoti Lahiri; Yun Lo; Bianca Ionela Slivinschi; Axel Imhof; Georg Jocher; Laura Strohm; Christian Behrends; Dieter Langosch; Holger Bronger; Christopher Nimsky; Jörg W Bartsch; Stanley R Riddell; Harald Steiner; Stefan F Lichtenthaler
Journal:  EMBO Mol Med       Date:  2022-09-07       Impact factor: 14.260

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.